Skip to main content
Glama

Markdown

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the read-only/idempotent annotations, the description reveals crucial behaviors: graceful degradation when GLEIF/OpenFIGI is unavailable, ambiguous matches returning figi_candidates rather than asserting, unresolved identifiers being explicitly listed, and each call cascading through multiple lookup endpoints. This is exactly the behavioral context an agent needs and is not present in annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but it is front-loaded with the core purpose and usage. Nearly every sentence carries necessary edge-case information for a complex multi-source lookup tool, though the heavy parenthetical style makes it less scannable than it could be.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity, the lack of an output schema, and the two parameter types, the description is remarkably complete. It covers supported entity types, identifier sources, input constraints, ambiguity handling, unresolved-result behavior, and upstream service failures, leaving no significant gap for an agent deciding to call it.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds substantial meaning beyond the schema: accepted input forms for company (ticker, CIK, ISIN, or name), drug input expectations, and the critical instruction to pass only the entity name, with the bond-issuer example. This materially improves correct invocation.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user phrasings and a clear verb-resource statement: resolve a user-spoken name to canonical/official identifiers that other tools require. It also distinguishes itself from siblings by positioning it as the first tool to use when a name needs an ID, and it enumerates supported entity types with their identifier outputs.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says 'Use FIRST whenever you have a name but need an ID,' which is strong, actionable guidance. It does not name specific competing tools or state when not to use it, but the context makes the intended usage clear and differentiates it from the broad sibling set.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Markdown toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Several tool clusters are hard to distinguish: the four ask_pipeworx variants overlap heavily (beta currently behaves identically to ask_pipeworx, and grounded shares routing), and the half-dozen prediction-market tools (bet_research, polymarket_edges, polymarket_arbitrage, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread) have fuzzy boundaries. Memory and markdown utilities are clear, but the overlapping data-query and prediction-market clusters create real misselection risk.

Naming Consistency4/5

Names are almost uniformly snake_case and mostly verb-first (ask_, compare_, extract_, scan_, validate_, remember, forget), which is predictable. Minor deviations like entity_profile, recent_changes, and polymarket_edges are noun-first but still follow the same lowercase_snake pattern, so no chaotic mixing of conventions exists.

Tool Count2/5

34 tools is heavy for a server seemingly named 'Markdown', especially when the majority are actually Pipeworx data-research and prediction-market tools. Several tools duplicate or wrap each other (ask_pipeworx_beta, scan_competitor_ai_presence, bet_research et al.), so the count feels bloated; it is not as extreme as 50+, but it exceeds a well-scoped set.

Completeness4/5

Within the actual dominant domain — structured data research plus prediction markets — the surface is broad: routing queries, grounded answers, deep research, entity profiles, comparisons, resolution, claim validation, semantic search, discoverability, subscriptions/alerts, and memory are all covered. Minor gaps exist (e.g. no direct pipeworx:// citation-fetch tool, and markdown support is thin), but the core workflows have no dead ends.

Resources